Antibacterial activity of recently approved antibiotics against methicillin-resistant Staphylococcus aureus (MRSA) strains: A systematic review and meta-analysis

Table 3 Antibacterial activity of dalbavancin against MRSA isolates based on year groups

Dalbavancin		MIC₅₀	MIC₉₀	MIC₅₀/₉₀	Susceptibility rate (%)
2010–2015	Median	0.06	0.1225	1	100
	Min.	0.008	0.06	1	98.8
	Max.	0.25	0.25	31.25	100
2016–2020	Median	0.094	0.12	1.276	100
	Min.	0.03	0.06	1	99.64
	Max.	0.125	0.125	2	100

ISSN: 1476-0711